Ortivus launched CoroNet in Italy and Spain

OrtivusFollowing the successful launch of CoroNet in Sweden, Ortivus now continues to build up its international sales of the system. Two of the most important markets in Europe are Italy and Spain where Ortivus now signs a partner agreement with the well-reputed and market leading company et medical devices - cardiette - CARDIOLINE.

The company, with main office in Milano, and its own subsidiaries in Spain has about 110 employees and a turnover of approximately 15 million Euro. Under the well-known brand "CARDIOLINE" et medical devices develops and promotes products such as ECG, HOLTER and STRESS-TEST solution and has a market share in Italy of approximately 40%. The company has an extensive network in Italy and Spain of cardiologists and other strategically relevant target groups for Ortivus products. In order to fully leverage on the brand recognition on the market CoroNet will be promoted under the co-brand "CARDIOLINE CoroNet".

"In et medical devices Ortivus have found a partner with a well established customer network of the kind Ortivus addresses with CoroNet. They have an organization, market presence and know-how, which fit excellent with our requirements. Furthermore, et medical's strategic decision to enlarge their portfolio with a dedicated cardiac monitoring system like CoroNet shows a top-level commitment and involvement which I believe will pay-off for both parties. We truly look forward to working together with et medical.", says Rain Eriksoo, VP Sales & Marketing at Ortivus.

"CoroNet is a strategic and hence very important addition to our overall product offering. We have scanned the market for a suitable monitoring solution to complete our portfolio and CoroNet, not only being a monitoring system but a highly innovative solution that brings an extra value to our offer and our customers is exactly what we have been looking for. With CoroNet in our portfolio we can offer our customers solutions that cover all parts of cardiology related care and improve the dissemination of our brand CARDIOLINE in the cardiology arena.", says Gian-Luca Ziliani, Marketing and Business Development Manager of et medical devices.

CoroNet is a patient monitoring system developed to specifically target hospitals and departments in the need of advanced cardiac monitoring and rehabilitation. CoroNet innovatively combines bedside and telemetry monitoring into a single seamless system. The solution has already gained a strong market share in Sweden: Karolinska in Stockholm, The University Hospital of Sahlgrenska in Gothenburg and The Academic Hospital in Uppsala are examples of prestigious hospitals that have selected Ortivus' system for their cardiology departments.

About Ortivus
Ortivus AB is a Healthcare IT company that offers information and decision-making support systems for Healthcare, Emergency Medical Services and Public Safety in Europe and North America. Ortivus AB is listed on the OMX Nordic Exchange Small Cap list and was established in 1985. Ortivus has approximately 165 employees and subsidiaries in Denmark, Germany, Great Britain, Canada, and the US. For further information please visit www.ortivus.com

About et medical Devices
et medical devices - cardiette - CARDIOLINE are highly specialized in the development, production, marketing and worldwide sales of cardiovascular technologies. The main solutions provided are integrated ECG recorders, Stress Test Systems, Holter ECG, ABPM, Defibrillators, Monitors, Rehabilitation, Selfhomecare, Telemedicine and Information Management Software. New dedicated research and development programs are progressively enlarging the products portfolio with especially patient oriented solutions. For further information please visit www.cardiette.biz www.cardioline.biz

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Computer Models Open Door to Far Mor…

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...

AI Model Identifies Potential Risk Genes…

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can...

AI Tool that may Assist Underserved Hosp…

As the fields of healthcare and technology increasingly evolve and intersect, researchers are collaborating on the best ways to use emerging technologies such as artificial intelligence (AI) to care for...